Table 1.
cfPWV | baPWV | |
---|---|---|
Strength | Regarded as the gold standard among non-invasive methods for measuring arterial stiffness | Simpler and quicker to measure, making it suitable for mass screening |
Supported by extensive clinical data and is the most validated measure | Offers insights into both central and peripheral arterial stiffness, providing a comprehensive assessment | |
Provides an assessment of central aortic stiffness | The equipment for baPWV is more affordable and readily available in many clinical settings | |
Minimally influenced by lower limb arterial disease | More reproducible with reduced variability due to its straightforward operator technique | |
Limitation | Can be uncomfortable for subjects during measurement | Reflects a mixed assessment of both central and peripheral arterial stiffness |
Demands specialized training and is more time-consuming to perform | Susceptible to alterations from conditions affecting peripheral arteries, particularly lower limb diseases | |
Less suitable for mass screening | May not be universally recognized or preferred for some research or clinical contexts | |
Does not provide insights into peripheral arterial stiffness | Lacks standardized normal values that are universally accepted | |
Might overestimate values in individuals with short stature | Predominantly utilized in Asian countries | |
Reference value | Abnormal ≥ 10 m/s |
Normal < 14 m/s Borderline ≥ 14 and < 18 m/s Abnormal ≥ 18 m/s |
cfPWV carotid-femoral pulse wave velocity, baPWV brachial-ankle pulse wave velocity